(Q51713786)

10 April 2018

title

In vitro activity of dermaseptin S4 derivatives against genital infections pathogens. (English)

1 reference

10 April 2018

2

Frédéric Tangy

1 reference

10 April 2018

Amira Zairi

1

1 reference

10 April 2018

Souhir Saadi

series ordinal

3

1 reference

10 April 2018

Khaled Hani

series ordinal

4

1 reference

10 April 2018

language of work or name

English

0 references

publication date

24 January 2008

1 reference

10 April 2018

Regulatory Toxicology and Pharmacology

published in

1 reference

10 April 2018

volume

50

1 reference

10 April 2018

issue

3

1 reference

10 April 2018

page(s)

353-358

1 reference

10 April 2018

[Cationic antimicrobial peptides: from innate immunity study to drug development. Up date]

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

In vitro antiviral activity of dermaseptins against herpes simplex virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion Pandinus imperator.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Intracellular targets of antibacterial peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

In vitro antiplasmodium effects of dermaseptin S4 derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Direct interaction of dermaseptin S4 aminoheptanoyl derivative with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Analysis of Membrane-Binding Properties of Dermaseptin Analogues: Relationships between Binding and Cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Defensins: antimicrobial peptides of innate immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Innate immunity. Ancient system gets new respect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Cationic peptides: a new source of antibiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Antibacterial activity of synthetic dermaseptins against growing and non-growing Escherichia coli cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Antimalarial activities of dermaseptin S4 derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Antimicrobial peptides in mammalian and insect host defence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Isolation, amino acid sequence, and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Isolation and structure of novel defensive peptides from frog skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Global phenotype screening and transcript analysis outlines the inhibitory mode(s) of action of two amphibian-derived, alpha-helical, cationic peptides on Saccharomyces cerevisiae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Differential expression of Candida albicans secreted aspartyl proteinase and phospholipase B genes in humans correlates with active oral and vaginal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Antibacterial properties of dermaseptin S4 derivatives with in vivo activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Peptides as weapons against microorganisms in the chemical defense system of vertebrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

In vitro activity of gemifloxacin against clinical isolates of Neisseria gonorrhoeae with and without mutations in the gyrA gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Interactions of the designed antimicrobial peptide MB21 and truncated dermaseptin S3 with lipid bilayers: molecular-dynamics simulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

In vitro anti-Neisseria gonorrhoeae activity of Terminalia macroptera leaves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Antimicrobial peptides of multicellular organisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

Protegrin structure and activity against Neisseria gonorrhoeae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.01.005

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YRTPH.2008.01.005

1 reference

10 April 2018

1 reference

10 April 2018